星空体育官方入口网站网址大全-登录入口官网

#β地中海贫血#

8篇内容 | 1265人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2176064, encodeId=20d221e606432, content=<a href='/topic/show?id=5adb6680eea' target=_blank style='color:#2F92EE;'>#激素#</a> <a href='/topic/show?id=aebc192307c' target=_blank style='color:#2F92EE;'>#β地中海贫血#</a> <a href='/topic/show?id=87a0e9031e' target=_blank style='color:#2F92EE;'>#GDF15#</a> <a href='/topic/show?id=1c5544842cd' target=_blank style='color:#2F92EE;'>#妊娠剧吐#</a>, objectTitle=Nature：重大进展！新研究揭示女性在怀孕期间会出现恶心和呕吐的原因，有望开发出潜在的治疗方法, objectType=article, longId=804950, objectId=c521804950d0, topicUrl=null, isHasObj=0, objectCover=https://msimg.bioon.com/bioon-com/20231214/1702508208524_2185383.png, objectUrl=/article/show_article.do?id=c521804950d0, replyNumber=0, likeNumber=50, createdTime=2023-12-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2092808, encodeId=b6322092808de, content=<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a>批准的<a href='/topic/show?id=60c232154fc' target=_blank style='color:#2F92EE;'>#创新药物#</a>，这里看到常见病，如<a href='/topic/show?id=91cf549e3f1' target=_blank style='color:#2F92EE;'>#抑郁症#</a>，<a href='/topic/show?id=13032e051f7' target=_blank style='color:#2F92EE;'>#便秘#</a>的治疗，也有<a href='/topic/show?id=5a8be955621' target=_blank style='color:#2F92EE;'>#罕见病#</a>，如<a href='/topic/show?id=aebc192307c' target=_blank style='color:#2F92EE;'>#β地中海贫血#</a>的<a href='/topic/show?id=567041e8055' target=_blank style='color:#2F92EE;'>#基因治疗#</a>上市。还有<a href='/topic/show?id=0eca955681e' target=_blank style='color:#2F92EE;'>#酶替代治疗#</a><a href='/topic/show?id=e6b910492475' target=_blank style='color:#2F92EE;'>#Xenpozyme#</a>，<a href='/topic/show?id=224b6e85219' target=_blank style='color:#2F92EE;'>#特利加压素#</a>治疗成人<a href='/topic/show?id=abc28138548' target=_blank style='color:#2F92EE;'>#肝肾综合征#</a> (HRS)等，整体来说，创新药呈现是加速发展的趋势。, objectTitle=FDA在2022年第三季度批准了哪些创新药（下）？, objectType=article, longId=742666, objectId=b6c8e42666e2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20221009/ab2e59afdf774f8881a31e168706d9f7.jpg, objectUrl=/article/show_article.do?id=b6c8e42666e2, replyNumber=0, likeNumber=161, createdTime=2022-10-10, rootId=0, userName=lifestar, userId=aa0e14, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6c8e42666e2, moduleTitle=FDA在2022年第三季度批准了哪些创新药（下）？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b6c8e42666e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1441443, encodeId=27881441443de, content=<a href='/topic/show?id=aebc192307c' target=_blank style='color:#2F92EE;'>#β地中海贫血#</a>, objectTitle=NEJM：Luspatercept用于治疗输血依赖型β地中海贫血, objectType=article, longId=190922, objectId=36a519092233, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36a519092233, replyNumber=0, likeNumber=90, createdTime=2020-03-28, rootId=0, userName=ms7258648636991762, userId=32454837595, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36a519092233, moduleTitle=NEJM：Luspatercept用于治疗输血依赖型β地中海贫血, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=36a519092233)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1441442, encodeId=ff0f144144215, content=<a href='/topic/show?id=aebc192307c' target=_blank style='color:#2F92EE;'>#β地中海贫血#</a>, objectTitle=Celgene的Reblozyl成为美国针对β地中海贫血的治疗药物, objectType=article, longId=182744, objectId=f017182e4470, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f017182e4470, replyNumber=0, likeNumber=72, createdTime=2019-11-11, rootId=0, userName=ms7258648636991762, userId=32454837595, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f017182e4470, moduleTitle=Celgene的Reblozyl成为美国针对β地中海贫血的治疗药物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f017182e4470)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1441441, encodeId=ff661441441af, content=<a href='/topic/show?id=aebc192307c' target=_blank style='color:#2F92EE;'>#β地中海贫血#</a>, objectTitle=Clin Chem：回旋共振质谱法和串联质谱法诊断血红蛋白病和β地中海贫血症, objectType=article, longId=181581, objectId=c697181581cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c697181581cf, replyNumber=0, likeNumber=75, createdTime=2019-10-21, rootId=0, userName=ms7258648636991762, userId=32454837595, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c697181581cf, moduleTitle=Clin Chem：回旋共振质谱法和串联质谱法诊断血红蛋白病和β地中海贫血症, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c697181581cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1441440, encodeId=0d6f14414406b, content=<a href='/topic/show?id=aebc192307c' target=_blank style='color:#2F92EE;'>#β地中海贫血#</a>, objectTitle=Blood：编辑异常剪接位点可有效恢复β地中海贫血患者的β-球蛋白的表达, objectType=article, longId=163409, objectId=286216340942, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=286216340942, replyNumber=0, likeNumber=64, createdTime=2019-04-03, rootId=0, userName=ms7258648636991762, userId=32454837595, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=286216340942, moduleTitle=Blood：编辑异常剪接位点可有效恢复β地中海贫血患者的β-球蛋白的表达, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=286216340942)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1441439, encodeId=46c91441439f2, content=<a href='/topic/show?id=aebc192307c' target=_blank style='color:#2F92EE;'>#β地中海贫血#</a>, objectTitle=Blood：基因编辑异常剪接位点可有效修复β地中海贫血的β球蛋白表达, objectType=article, longId=159559, objectId=25931595590d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25931595590d, replyNumber=0, likeNumber=109, createdTime=2019-02-08, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25931595590d, moduleTitle=Blood：基因编辑异常剪接位点可有效修复β地中海贫血的β球蛋白表达, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=25931595590d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1441438, encodeId=1c3d14414386f, content=<a href='/topic/show?id=aebc192307c' target=_blank style='color:#2F92EE;'>#β地中海贫血#</a>, objectTitle=Blood：β地中海贫血的新的潜在治疗靶点——转铁蛋白受体2, objectType=article, longId=148861, objectId=180d148861ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=180d148861ff, replyNumber=0, likeNumber=64, createdTime=2018-09-16, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=180d148861ff, moduleTitle=Blood：β地中海贫血的新的潜在治疗靶点——转铁蛋白受体2, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=180d148861ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1441437, encodeId=f316144143ef0, content=<a href='/topic/show?id=aebc192307c' target=_blank style='color:#2F92EE;'>#β地中海贫血#</a>, objectTitle=二甲双胍新疗效：治疗镰状细胞病和β地中海贫血, objectType=article, longId=87434, objectId=82548e4345f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82548e4345f, replyNumber=0, likeNumber=70, createdTime=2017-01-14, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82548e4345f, moduleTitle=二甲双胍新疗效：治疗镰状细胞病和β地中海贫血, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=82548e4345f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

β地中海贫血

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#激素# #β地中海贫血# #GDF15# #妊娠剧吐#

2023-12-20发表于上海

lifestar (审核中...)

前往app查看评论内容

#FDA#批准的#创新药物#，这里看到常见病，如#抑郁症#，#便秘#的治疗，也有#罕见病#，如#β地中海贫血#的#基因治疗#上市。还有#酶替代治疗##Xenpozyme#，#特利加压素#治疗成人#肝肾综合征# (HRS)等，整体来说，创新药呈现是加速发展的趋势。

FDA在2022年第三季度批准了哪些创新药（下）？

2022-10-10

ms7258648636991762 (审核中...)

前往app查看评论内容

#β地中海贫血#

NEJM：Luspatercept用于治疗输血依赖型β地中海贫血

2020-03-28

ms7258648636991762 (审核中...)

前往app查看评论内容

#β地中海贫血#

Celgene的Reblozyl成为美国针对β地中海贫血的治疗药物

2019-11-11

ms7258648636991762 (审核中...)

前往app查看评论内容

#β地中海贫血#

Clin Chem：回旋共振质谱法和串联质谱法诊断血红蛋白病和β地中海贫血症

2019-10-21

ms7258648636991762 (审核中...)

前往app查看评论内容

#β地中海贫血#

Blood：编辑异常剪接位点可有效恢复β地中海贫血患者的β-球蛋白的表达

2019-04-03

zhouqu_8 (审核中...)

前往app查看评论内容

#β地中海贫血#

Blood：基因编辑异常剪接位点可有效修复β地中海贫血的β球蛋白表达

2019-02-08

zhouqu_8 (审核中...)

前往app查看评论内容

#β地中海贫血#

Blood：β地中海贫血的新的潜在治疗靶点——转铁蛋白受体2

2018-09-16

zhouqu_8 (审核中...)

前往app查看评论内容

#β地中海贫血#

二甲双胍新疗效：治疗镰状细胞病和β地中海贫血

2017-01-14

科室
- - 订阅+
  - 更多科室
工具
服务